Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 公共衛生學院
  3. 流行病學與預防醫學研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/25502
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor陳為堅(Wei J. Chen)
dc.contributor.authorShu-Sen Changen
dc.contributor.author張書森zh_TW
dc.date.accessioned2021-06-08T06:16:09Z-
dc.date.copyright2007-02-02
dc.date.issued2007
dc.date.submitted2007-01-30
dc.identifier.citationAmerican Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
Benjamini, Y., and Hochberg, Y. Controlling The False Discovery Rate - A Practical And Powerful Approach To Multiple Testing. Journal Of The Royal Statistical Society Series B-Methodological, 57(1):289-300, 1995.
Benjamini, Y., and Yekutieli, D. The control of the false discovery rate in multiple testing under dependency. Annals Of Statistics, 29(4):1165-1188, 2001.
Berardesca, E., and Maibach, H.I. Racial differences in pharmacodynamic response to nicotinates in vivo in human skin: black and white. Acta Derm Venereol, 70(1):63-6, 1990.
Berger, G.E.; Wood, S.J.; Pantelis, C.; Velakoulis, D.; Wellard, R.M.; and McGorry, P.D. Implications of lipid biology for the pathogenesis of schizophrenia. Aust N Z J Psychiatry, 36(3):355-66, 2002.
Bosveld-van Haandel, L.; Knegtering, R.; Kluiter, H.; and van den Bosch, R.J. Niacin skin flushing in schizophrenic and depressed patients and healthy controls. Psychiatry Res, 143(2-3):303-6, 2006.
Chen, W.J.; Liu, S.K.; Chang, C.J.; Lien, Y.J.; Chang, Y.H.; and Hwu, H.G. Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. Am J Psychiatry, 155(9):1214-20, 1998.
Covault, J.; Pettinati, H.; Moak, D.; Mueller, T.; and Kranzler, H.R. Association of a long-chain fatty acid-CoA ligase 4 gene polymorphism with depression and with enhanced niacin-induced dermal erythema. Am J Med Genet B Neuropsychiatr Genet, 127(1):42-7, 2004.
Faraone, S.V.; Tsuang, M.T.; and Tsuang, D.W. Genetics of Mental Disorders: What Practitioners and Students Need to Know New York: Guilford 2001.
Farmer, A.; McGuffin, P.; and Gottesman, II. Problems and pitfalls of the family history positive and negative dichotomy: response to Dalen. Schizophr Bull, 16(3):367-70, 1990.
Fenton, W.S.; Hibbeln, J.; and Knable, M. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry, 47(1):8-21, 2000.
Fiedler, P.; Wolkin, A.; and Rotrosen, J. Niacin-induced flush as a measure of prostaglandin activity in alcoholics and schizophrenics. Biol Psychiatry, 21(13):1347-50, 1986.
Glen, A.I.; Cooper, S.J.; Rybakowski, J.; Vaddadi, K.; Brayshaw, N.; and Horrobin, D.F. Membrane fatty acids, niacin flushing and clinical parameters. Prostaglandins Leukot Essent Fatty Acids, 55(1-2):9-15, 1996.
Goldin, L.R.; DeLisi, L.E.; and Gershon, E.S. Unravelling the relationship between genetic and environmental risk factors in psychiatric disorders. Br J Psychiatry, 151:302-5, 1987.
Gottesman, II, and Gould, T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry, 160(4):636-45, 2003.
Gueorguieva, R., and Krystal, J.H. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry, 61(3):310-7, 2004.
Hanson, D.R., and Gottesman, II. Theories of schizophrenia: a genetic-inflammatory-vascular synthesis. BMC Med Genet, 6:7, 2005.
Hoffer, A. Niacin Therapy in Psychiatry. Springfield, IL, 1962.
Horrobin, D.F. Schizophrenia: a biochemical disorder? Biomedicine, 32(2):54-5, 1980.
Horrobin, D.F. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res, 30(3):193-208, 1998.
Hudson, C.; Gotowiec, A.; Seeman, M.; Warsh, J.; and Ross, B.M. Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia. Biol Psychiatry, 46(3):401-5, 1999.
Hudson, C.J.; Lin, A.; Cogan, S.; Cashman, F.; and Warsh, J.J. The niacin challenge test: clinical manifestation of altered transmembrane signal transduction in schizophrenia? Biol Psychiatry, 41(5):507-13, 1997.
Hwu, H.G.; Faraone, S.V.; Liu, C.M.; Chen, W.J.; Liu, S.K.; Shieh, M.H.; Hwang, T.J.; Tsuang, M.M.; OuYang, W.C.; Chen, C.Y.; Chen, C.C.; Lin, J.J.; Chou, F.H.; Chueh, C.M.; Liu, W.M.; Hall, M.H.; and Tsuang, M.T. Taiwan schizophrenia linkage study: the field study. Am J Med Genet B Neuropsychiatr Genet, 134(1):30-6, 2005.
Katzman, M.; Cornacchi, S.; Coonerty-Femiano, A.; Hughes, B.; Vermani, M.; Struzik, L.; and Ross, B.M. Methyl nicotinate-induced vasodilation in generalized social phobia. Neuropsychopharmacology, 28(10):1846-51, 2003.
Kendler, K.S. The sporadic v. familial classification given aetiological heterogeneity: II. Power analyses. Psychol Med, 18(4):991-9, 1988.
Laird, N.M., and Ware, J.H. Random-effects models for longitudinal data. Biometrics, 38(4):963-74, 1982.
Lewis, S.W.; Reveley, A.M.; Reveley, M.A.; Chitkara, B.; and Murray, R.M. The familial/sporadic distinction as a strategy in schizophrenia research. Br J Psychiatry, 151:306-13, 1987.
Lin, S.H.; Liu, C.M.; Chang, S.S.; Hwu, H.G.; Liu, S.K.; Hwang, T.J.; Hsieh, M.H.; Guo, S.C.; and Chen, W.J. Familial aggregation in skin flush response to niacin patch among schizophrenic patients and their nonpsychotic relatives. Schizophr Bull, 33(1):174-82, 2007.
Liu, C.M.; Chang, S.S.; Liao, S.C.; Hwang, T.J.; Hsieh, M.H.; Liu, S.K.; Chen, W.J.; and Hwu, H.G. Absent response to niacin skin patch is specific to schizophrenia and independent of smoking. Psychiatry Res, accepted.
Lyons, M.J.; Faraone, S.V.; Kremen, W.S.; and Tsuang, M.T. Familial and sporadic schizophrenia. A simulation study of statistical power. Schizophr Res, 2(4-5):345-53, 1989.
Maclean, R.; Ward, P.E.; Glen, I.; Roberts, S.J.; and Ross, B.M. On the relationship between methylnicotinate-induced skin flush and fatty acids levels in acute psychosis. Prog Neuropsychopharmacol Biol Psychiatry, 27(6):927-33, 2003.
Messamore, E. Relationship between the niacin skin flush response and essential fatty acids in schizophrenia. Prostaglandins Leukot Essent Fatty Acids, 69(6):413-9, 2003.
Messamore, E.; Hoffman, W.F.; and Janowsky, A. The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study. Schizophr Res, 62(3):251-8, 2003.
Morrow, J.D.; Awad, J.A.; Oates, J.A.; and Roberts, L.J., 2nd. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. J Invest Dermatol, 98(5):812-5, 1992.
Morrow, J.D.; Parsons, W.G., 3rd; and Roberts, L.J., 2nd. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. Prostaglandins, 38(2):263-74, 1989.
Mosher, L.R. Nicotinic acid side effects and toxicity: a review. Am J Psychiatry, 126(9):1290-6, 1970.
NIMH Genetics Initiative. Diagnostic Interview for Genetic Studies. Rockville, MD: National Institute of Mental Health, 1992a.
NIMH Genetics Initiative. Family Interview for Genetic Studies. Rockville, MD: National Institute of Mental Health, 1992b.
Nurnberger, J.I., Jr.; Blehar, M.C.; Kaufmann, C.A.; York-Cooler, C.; Simpson, S.G.; Harkavy-Friedman, J.; Severe, J.B.; Malaspina, D.; and Reich, T. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry, 51(11):849-59; discussion 863-4, 1994.
Plummer, N.A.; Hensby, C.N.; Black, A.K.; and Greaves, M.W. Prostaglandin activity in sustained inflammation of human skin before and after aspirin. Clin Sci Mol Med, 52(6):615-20, 1977.
Puri, B.K. Impaired phospholipid-related signal transduction in advanced Huntington's disease. Exp Physiol, 86(5):683-5, 2001.
Puri, B.K.; Easton, T.; Das, I.; Kidane, L.; and Richardson, A.J. The niacin skin flush test in schizophrenia: a replication study. Int J Clin Pract, 55(6):368-70, 2001.
Puri, B.K.; Hirsch, S.R.; Easton, T.; and Richardson, A.J. A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry, 26(1):49-52, 2002.
Puri, B.K., and Singh, I. Normal phospholipid-related signal transduction in autism. Prog Neuropsychopharmacol Biol Psychiatry, 26(7-8):1405-7, 2002.
Ross, B.M.; Hughes, B.; Turenne, S.; Seeman, M.; and Warsh, J.J. Reduced vasodilatory response to methylnicotinate in schizophrenia as assessed by laser Doppler flowmetry. Eur Neuropsychopharmacol, 14(3):191-7, 2004.
Roy, M.A., and Crowe, R.R. Validity of the familial and sporadic subtypes of schizophrenia. Am J Psychiatry, 151(6):805-14, 1994.
Rybakowski, J., and Weterle, R. Niacin test in schizophrenia and affective illness. Biol Psychiatry, 29(8):834-6, 1991.
Shah, S.H.; Ramchand, C.N.; and Peet, M. The niacin skin flush test: first-degree relatives show responses intermediate between patients and controls. Schizophr Res, 36(1-3):314, 1999.
Shah, S.H.; Vankar, G.K.; Peet, M.; and Ramchand, C.N. Unmedicated schizophrenic patients have a reduced skin flush in response to topical niacin. Schizophr Res, 43(2-3):163-4, 2000.
Smesny, S.; Berger, G.; Rosburg, T.; Riemann, S.; Riehemann, S.; McGorry, P.; and Sauer, H. Potential use of the topical niacin skin test in early psychosis -- a combined approach using optical reflection spectroscopy and a descriptive rating scale. J Psychiatr Res, 37(3):237-47, 2003.
Smesny, S.; Riemann, S.; Riehemann, S.; Bellemann, M.E.; and Sauer, H. [Quantitative measurement of induced skin reddening using optical reflection spectroscopy--methodology and clinical application]. Biomed Tech (Berl), 46(10):280-6, 2001.
Smesny, S.; Rosburg, T.; Klemm, S.; Riemann, S.; Baur, K.; Rudolph, N.; Grunwald, S.; and Sauer, H. The influence of age and gender on niacin skin test results - implications for the use as a biochemical marker in schizophrenia. J Psychiatr Res, 38(5):537-43, 2004.
Smesny, S.; Rosburg, T.; Riemann, S.; Baur, K.; Rudolph, N.; Berger, G.; and Sauer, H. Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia. Prostaglandins Leukot Essent Fatty Acids, 72(6):393-402, 2005.
Tavares, H.; Yacubian, J.; Talib, L.L.; Barbosa, N.R.; and Gattaz, W.F. Increased phospholipase A2 activity in schizophrenia with absent response to niacin. Schizophr Res, 61(1):1-6, 2003.
Tsuang, H.C.; Lin, S.H.; Liu, S.K.; Hsieh, M.H.; Hwang, T.J.; Liu, C.M.; Hwu, H.G.; and Chen, W.J. More severe sustained attention deficits in nonpsychotic siblings of multiplex schizophrenia families than in those of simplex ones. Schizophr Res, 87(1-3):172-80, 2006.
Tsuang, M. Schizophrenia: genes and environment. Biol Psychiatry, 47(3):210-20, 2000.
Tsuang, M.T.; Lyons, M.J.; and Faraone, S.V. Heterogeneity of schizophrenia. Conceptual models and analytic strategies. Br J Psychiatry, 156:17-26, 1990.
Turenne, S.D.; Seeman, M.; and Ross, B.M. An animal model of nicotinic-acid-induced vasodilation: effect of haloperidol, caffeine and nicotine upon nicotinic acid response. Schizophr Res, 50(3):191-7, 2001.
Waldo, M.C. Co-distribution of sensory gating and impaired niacin flush response in the parents of schizophrenics. Schizophr Res, 40(1):49-53, 1999.
Ward, P.E.; Sutherland, J.; Glen, E.M.; and Glen, A.I. Niacin skin flush in schizophrenia: a preliminary report. Schizophr Res, 29(3):269-74, 1998.
Wilson, D.W., and Douglass, A.B. Niacin skin flush is not diagnostic of schizophrenia. Biol Psychiatry, 21(10):974-7, 1986.
Zeger, S.L., and Liang, K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics, 42(1):121-30, 1986.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/25502-
dc.description.abstract目的:在先前的研究中,我們曾報告在精神分裂症患者及其家庭成員中之異常菸鹼酸皮膚貼片紅腫反應有家族聚集之現象。然而,尚未有研究探討此異常之紅腫反應是否與精神分裂症之家族負荷有關。本研究是比較兩類精神分裂症家庭之病人及親屬的菸鹼酸紅腫反應,即多發性家庭(家庭中至少有一對發病手足)及單發性家庭(核心家庭中僅有一位罹病成員)。
方法:研究個案為來自多發性家庭的病人及其一等親屬(311位罹患精神分裂症或分裂精感性疾患之指引個案,180位雙親與52位無病手足)、來自單發性家庭的病人及其一等親屬(176位指引個案,260位雙親與80位無病手足),以及90位正常對照個案。我們使用三種不同濃度之菸鹼酸貼片(0.001M、0.01M與0.1M),貼附於前臂皮膚上五分鐘,於移去貼片後五、十及十五分鐘時為紅腫程度評分(0,1,2及3分)。
結果:和來自單發性家庭的對比個案相較下,多發性家庭病人及其非精神病性之一等血親屬均有較為減弱之紅腫反應,而且此差異在使用濃度0.1M之菸鹼酸貼片時最為顯著,在此濃度下,來自多發性家庭的23-57%病人、27-56%父母及19-40%無病手足未呈現紅腫反應,相較之下,單發性家庭的對應個案未呈現紅腫反應之比例則分別為5-29%、3-17%及5-18%,而正常對照則是0-30%。此皮膚紅腫反應在三組之間存在一梯度:正常對照組最強,其次為單發性家庭成員,多發性家庭成員之反應為最弱。
結論:來自多發性家庭之精神分裂症病人及其無病親屬有較高之家庭負荷,同時菸鹼酸皮膚貼片紅腫反應亦更為異常。此項發現有助於未來精神分裂症遺傳病因之研究。
zh_TW
dc.description.abstractObjective: We previously reported familial aggregation in flush response to niacin skin patch among schizophrenia patients and their nonpsychotic relatives. However, little is known whether this abnormal niacin response is associated with familial loading for schizophrenia. This study compared niacin response in subjects from families with a sib-pair with schizophrenia (multiplex families) and those from families with only one member affected (simplex families).
Method: Subjects were schizophrenia patients and their first-degree relatives from multiplex families (311 probands with schizophrenia or schizoaffective disorder, 180 parents, and 52 non-affected siblings) and simplex families (176 schizophrenia probands, 260 parents, and 80 non-affected siblings) as well as 90 healthy comparison subjects. Niacin patches of three concentrations (0.001M, 0.01M, 0.1M) were applied to the forearm skin, and the flush response was rated at 5, 10 and 15 minutes, respectively, with a 4-point scale.
Results: More blunted response to topical niacin was shown in schizophrenia probands and their nonpsychotic relatives from multiplex families than their counterparts from simplex families. The greatest degree of differentiation between groups were revealed using 0.1M of niacin, with nonflush response in 23-57% of probands, 27-56% of parents, and 19-40% of siblings from multiplex families in contrast to 5-29%, 3-17% and 5-18% of their counterparts from simplex families, respectively, as well as in 0-30% of normal controls.
Conclusions: Flush response to skin niacin is more impaired in schizophrenia patients as well as their relatives from families with higher loading for schizophrenia. This finding might be useful for future genetic dissection of schizophrenia.
en
dc.description.provenanceMade available in DSpace on 2021-06-08T06:16:09Z (GMT). No. of bitstreams: 1
ntu-96-R93842017-1.pdf: 409814 bytes, checksum: 93857a1b35166039fe63e8081a3da014 (MD5)
Previous issue date: 2007
en
dc.description.tableofcontents口試委員會審定書 i
口試委員會審定書(英文)ii
誌謝 iii
中文摘要 iv
英文摘要 v
1. Introduction 1
1.1 Background 1
1.1.1 Impaired niacin flush response in schizophrenia 1
1.1.2 Niacin subsensitivity as a potential genetic indicator for schizophrenia 2
1.1.3 The familial-sporadic distinction in etiological dissection of schizophrenia 3
1.2 Study Design and Aims 4
2. Method 6
2.1 Subjects 6
2.1.1 Multiplex families 6
2.1.2 Simplex families 6
2.1.3 Healthy comparison subjects 7
2.1.4 Inclusion and exclusion criteria 7
2.2 Interview Instruments and Diagnostic Procedures 8
2.3 Niacin Skin Test 9
2.3.1 Protocol 9
2.3.2 Reliability 9
2.3.3 Definition of nonflushness and volumetric niacin response 15 (VNR15) 9
2.4 Data Analysis 10
2.4.1 Statistical models 10
2.4.2 False discovery rate and effect sizes 11
3. Results 12
3.1 Subject Characteristics 12
3.2 Flush Score Distribution 12
3.3 Proportion of Nonflushness 12
3.4 Mean Niacin Response Scores 13
3.4.1 Volumetric niacin response 14
3.4.2 Comparisons with normal controls 14
4. Discussion 15
4.1 Range of Flush Response 15
4.1.1 Response at the lower end 15
4.1.2 Response at the upper end 16
4.2 Discrimination between Groups 16
4.2.1 Effects of concentration and time 16
4.2.2 Choice of response indexes 17
4.2.2.1 Original continuous scores and dichotomous flush response 17
4.2.2.2 Volumetric niacin response 15 (VNR15) 18
4.3 Strengths of Current Study 18
4.4 Limitations 19
4.5 Implications  21
4.6 Conclusions 22
Reference 28
dc.language.isozh-TW
dc.title精神分裂症之菸鹼酸皮膚貼片紅腫反應異常與高家族負荷之關聯性zh_TW
dc.titleHigher Familial Loading Associates with Impaired Flush Response to Niacin Skin Patch among Schizophrenia Patients and Their Nonpsychotic Relativesen
dc.typeThesis
dc.date.schoolyear95-1
dc.description.degree碩士
dc.contributor.coadvisor胡海國(Hai-Gwo Hwu)
dc.contributor.oralexamcommittee李文宗,藍先元
dc.subject.keyword精神分裂症,家庭負荷,無病親屬,菸鹼酸,皮膚測試,zh_TW
dc.subject.keywordschizophrenia,familial loading,nonpsychotic relatives,niacin,skin test,en
dc.relation.page32
dc.rights.note未授權
dc.date.accepted2007-01-30
dc.contributor.author-college公共衛生學院zh_TW
dc.contributor.author-dept流行病學研究所zh_TW
顯示於系所單位:流行病學與預防醫學研究所

文件中的檔案:
檔案 大小格式 
ntu-96-1.pdf
  目前未授權公開取用
400.21 kBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved